The Life Rivals Who Never Have to Be CheapestWide moat

PZU's life business holds around 44 percent of its market, against roughly 27 percent in non-life¹. On PZU's own count of regular-premium business it was 41,0% after the third quarter of 2025, against 14,2% for Allianz, the next group². Two shares in the same company, in the same country, far apart. The reason is that life insurance in Poland is sold to a different buyer.

The bulk of it is group protection: a contract signed with an employer, covering the workforce, renewed at the level of a human-resources department rather than an individual. Nobody in that arrangement opens a comparison site. Switching means renegotiating a benefit that thousands of employees already understand, re-enrolling all of them, and explaining to the works council why the new provider is better. The premiums per person are small and the administrative friction is large, which is exactly the combination that produces inertia.

Then comes the part that makes the franchise unusual. When an employee leaves that employer — changes jobs, or retires — Polish group policies can be individually continued, and PZU reports the resulting business as its own premium line. A customer originally acquired through somebody else's payroll becomes a direct, long-duration relationship at no acquisition cost, often for the rest of their life. It is the closest thing in this company to recurring revenue, and it is why a 44 percent share persists in a market where the motor share has to be re-won every twelve months.

The competition here is real but different in kind. Allianz became the second-largest life insurer in Poland by buying Aviva's book rather than by winning contracts, which is the tell: in group life you take a rival's customers by acquiring the rival.

The number to watch is not the share, which moves slowly. It is the premium on individually continued policies. If it stops growing, the conveyor belt from employer contracts into lifelong direct customers has stopped turning.